Filing Details

Accession Number:
0001178913-22-000219
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-24 16:17:47
Reporting Period:
2022-01-20
Accepted Time:
2022-01-24 16:17:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1638097 Entera Bio Ltd. ENTX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1766208 Phillip Schwartz Kiryat Hadassah,
Minrav Building, 5Th Floor
Jerusalem L3 9112002
President Of R&D Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value Nis 0.0000769 Per Share Acquisiton 2022-01-20 10,000 $2.53 607,410 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.49 to $2.56, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., anIsraeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the rangeset forth in this footnote (1) to this Form 4.